Stock BIO3 BIOTEST AG
Add to a list
To use this feature you must be a member
Log inSign up

All News Biotest AG

Equities

BIO3

DE0005227235

Market Closed - Xetra
Other stock markets
 11:36:18 2024-05-13 am EDT 		5-day change 1st Jan Change
27.8 EUR 0.00% Intraday chart for Biotest AG -0.71% -10.32%
May. 07 Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Apr. 19 Biotest Launches New Plasma Collection Center in Germany MT

All News

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Biotest : Speech of Peter Janssen - German Version
PU
Ex-dividend day for final dividend
FA
Biotest AG: Annual General Meeting approves dividend distribution
EQ
Biotest Aktiengesellschaft Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Biotest increased sales by 83.6% to Euro 215.2 million in first quarter 2024
EQ
Biotest Launches New Plasma Collection Center in Germany
MT
Biotest AG opens 12th plasma collection centre in Germany
EQ
Biotest AG increased sales by 32% in the financial year 2023
EQ
Biotest : Sustainability report Declaration of compliance 2023
PU
Biotest Aktiengesellschaft Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Biotest : Invitation / Agenda of Annual General Meeting 2024
PU
Biotest : Notes on agenda item 1 - German Version
PU
Biotest achieves EBIT forecast for 2023
EQ
Karl Lauterbach visits Biotest AG's plasma donation centre in Cologne and emphasises important contribution to patient care
EQ
Biotest successfully meets primary endpoint in phase III trial with Fibrinogen concentrate
EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
Biotest AG opens 11th plasma collection centre in Germany
EQ
AFR: Biotest AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
EQ
Biotest expands its clinical development program for trimodulin to patients with community-acquired pneumonia (CAP)
EQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. BIO3 Stock
  4. News Biotest AG
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW